Swiss BioQuant AG specialises in bioanalytical studies conducted to the highest standards. For this, it uses the very latest analytical technology especially HPLC-MS/MS and ELISA, allowing routine determinations to be performed as far as the bottom of the pg/mL range. It has a capacity of more than 1500 samples a day. Focus are:
 

• Analytical support for preclinical studies
• Pharmacokinetics and Toxicokinetics (plasma, urine, tissue analysis)
• Analytical support for clinical studies
• Bioavailability and bioequivalence studies
• Metabolite identification using high resolution accurate mass spectrometry (Orbitrap)

More than 20 years experience in LC-MS/MS and ELISA bioanalysis for drug, metabolite and biomarker determination in preclinical and clinical studies. Bioanalytical responsibilities for several hundreds of studies from new drug entities and generics applications.